Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Drug Development
Sanofi’s Zerhouni stepping down as research chief
by Lisa M. Jarvis
April 29, 2018
| A version of this story appeared in
Volume 96, Issue 18
Credit: Sanofi
Zerhouni
Credit: Roche
Reed
Sanofi’s head of R&D, Elias Zerhouni, will retire this summer. Zerhouni joined the big pharma firm in 2009, not long after stepping down as director of the U.S. National Institutes of Health. During his tenure, Sanofi put its R&D operations through an overhaul that included the sale or closure of multiple research sites. Zerhouni will be succeeded by John C. Reed, who currently leads research and early development at Roche.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X